HomeShopNA Semax 50 mg
NA Semax 50 mg 50 mg - Research Peptide | Pepcore

NA Semax 50 mg

189.00
In Stock
Size
Optional Lab Accessories
Bacteriostatic Water
Insulin Needles
Alcohol Swabs
1

For laboratory research use only. Not for human or veterinary use.

1–2 day delivery
1–2 day delivery
EU-wide tracked shipping
≥99% HPLC Purity
≥99% HPLC Purity
Third-party batch verified
COA Included
Lab report with every order
Discreet shipping
Secure & private packaging
Secure Payments
PayPalSEPABitcoin
Order before 12:00 for same-day shipping
Order now, ships next business day
OrderedToday
Shipped13 Apr
Delivered14 Apr16 Apr
Product Specifications
Format
Lyophilized powder
Strength
50 mg
Purity
99%
Testing
Third-party HPLC/MS
CAS
2920938-90-3
Intended use
Research only

Description

NA Semax 50mg peptide is an N-acetylated derivative of Semax, a synthetic ACTH-derived regulatory peptide studied in experimental neurobiology and peptide signaling research. Published work describes Semax as a synthetic melanocortin-related peptide, while separate chemical studies show that N-terminal acetylation of Semax alters the chemical and biological properties of the parent molecule. This makes NA Semax a relevant laboratory compound for research focused on peptide modification, neuroactive signaling, and structure-function relationships in ACTH-derived analogues.

Research interest in NA Semax 50mg peptide centers on how N-terminal acetylation may influence the behavior of the Semax scaffold in experimental systems. A published study on Ac-Semax reported that acetylation of the N-terminal amino group changed Semax metal-binding behavior and modified aspects of its biological profile, highlighting the importance of the free N-terminus in the parent peptide’s activity (Magrì et al., 2016 — Journal of Inorganic Biochemistry). Because Semax itself has been widely studied as an ACTH-derived neuropeptide, NA Semax is also relevant to comparative research on peptide stability, receptor-associated signaling, and analogue optimization.

Current research applications for NA Semax 50mg peptide include comparative Semax-analogue studies, experimental neuroprotection models, peptide chemistry investigations, and broader work on ACTH-derived regulatory compounds. Published Semax studies have shown transcriptomic effects in rat brain ischemia models, including altered expression of genes related to inflammation, vascular responses, and neurotransmission, which supports a cautious mechanism-oriented positioning of related analogues in laboratory research (Medvedeva et al., 2014 — BMC Genomics; Filippenkov et al., 2020 — International Journal of Molecular Sciences). Given the limited direct public literature on NA Semax itself, conservative research-focused language is the most credible way to describe this compound.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

See also: Semax, Selank, Adamax

Related products

189.00